Research AppraisalRandomised Controlled Trial

Prevalence and types of anxiety disorders among patients with cardiac conditions and elevated HADS-A scores: findings from the initial screening phase of the Heart and Mind trial in Denmark

BMJ openBerg, Selina Kikkenborg, Rasmussen, Line Ryberg, Thorup, Charlotte Brun et al.8 May 2026DOI

Clinical Snapshot

60CEBM
Evidence: ModerateRandomised Controlled Trial

PICO Framework

P — PopulationPatients with arrhythmia, heart failure, or ischaemic heart disease with HADS-A scores ≥8
I — InterventionStructured Clinical Interview for DSM (SCID) assessment
C — ComparatorHADS-A screening tool
O — OutcomesPrevalence and types of anxiety disorders confirmed by SCID diagnostic criteria

Bottom Line

This Danish study validates HADS-A screening in cardiac patients, finding that 84% of those scoring ≥8 meet formal anxiety disorder criteria. Among 7816 cardiac patients screened, 23% had elevated anxiety scores, with generalised anxiety disorder (61%) and panic disorder (23%) being most common. While the high positive predictive value supports routine HADS-A screening in cardiology practice, the study's major limitation is selection bias - only 22% of eligible patients consented to diagnostic interviews. The findings support systematic anxiety screening in cardiac populations, but clinicians should be aware that the true prevalence may differ from these volunteer-based estimates. The results align with established links between cardiac disease and anxiety, reinforcing the need for integrated cardiac-psychiatric care approaches in Australian practice.

Evidence: Moderate

Key Findings

  • P Value: Not reported for primary outcome

  • Effect Size: Positive predictive value of 84% for HADS-A screening

  • Primary Outcome: 84% of patients with HADS-A ≥8 met SCID criteria for anxiety disorder

  • Nnt Or Sensitivity: Sensitivity cannot be calculated without false negative data

  • Confidence Interval: Not reported

Clinical Application

HADS-A is brief, validated, and easily implemented in routine cardiac care Relevant to Australian cardiology practice; HADS widely used; supports RACGP guidelines on mental health screening in chronic disease Patients with cardiac conditions (arrhythmia, heart failure, ischaemic heart disease) in cardiology and primary care settings

Abstract

OBJECTIVES: To identify whether patients with arrhythmia, heart failure or ischaemic heart disease presenting with anxiety symptoms measured by the Hospital Anxiety and Depression Scale (HADS) have identifiable anxiety according to the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders (SCID) and, if so, which type of anxiety disorder based on the SCID. DESIGN: Initial screening data from the Heart and Mind randomised clinical trial. SETTING: Patients with arrhythmia, heart failure or ischaemic heart disease were screened using HADS, and patients with a HADS-anxiety (HADS-A) score≥8 were invited to participate. Participants were interviewed by trained cardiac nurses using the SCID to determine whether they met the criteria for anxiety and, if so, the type of anxiety disorder. RESULTS: Of the 7816 patients who completed the HADS questionnaire, 1803 (23%) had a HADS-A score≥8. Among these, 398 (22%) agreed to the SCID interview, and 336 (84%) met the diagnostic criteria for an anxiety disorder. The mean age was 61 years, with 40% being female. The mean HADS-A score was 11.3 (SD=2.7). The most common types of anxiety were generalised anxiety disorder (61%), panic disorder (23%) and specific phobia (8%). CONCLUSIONS: The majority of individuals identified by the instrument also met the diagnostic criteria for an anxiety disorder. Generalised anxiety disorder and panic disorder were the most prevalent subtypes. Anxiety was common across the cardiac population, underscoring the need for routine assessment and targeted intervention in clinical practice. TRIAL REGISTRATION NUMBER: NCT04582734.

References

  1. 1.Berg, S. K., Rasmussen, L. R., Thorup, C. B., Rasmussen, T. B., Christensen, A. V., Hammer, C. B., Jorgensen, M. B., Svendsen, J. H., Risom, S. S., Juul, C., & Schjødt, I. (2026). Prevalence and types of anxiety disorders among patients with cardiac conditions and elevated HADS-A scores: findings from the initial screening phase of the Heart and Mind trial in Denmark. BMJ Open. https://doi.org/10.1136/bmjopen-2025-113682
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service